Clinical Trial Update: Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2

View source ↗

Summary

A clinical trial update from Massachusetts General Hospital describes longitudinal at-home smell testing to detect SARS-CoV-2 infection, focusing on individuals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Anosmia, Asymptomatic COVID-19 | Status: ACTIVE_NOT_RECRUITING